Article

The influence of gender on loss of consciousness with sevoflurane or propofol

Emory University, Atlanta, Georgia, United States
Anesthesia & Analgesia (Impact Factor: 3.42). 09/2005; 101(2):377-81, table of contents. DOI: 10.1213/01.ANE.0000154534.71371.4F
Source: PubMed

ABSTRACT Studies have suggested that hypnotic requirements for general anesthesia and emergence may be influenced by gender. In this study, we examined the effect of gender on the hypnotic requirement for loss of consciousness (LOC) using either a volatile (sevoflurane) or an IV (propofol) anesthetic. One-hundred-fifteen unpremedicated, ASA physical status I-II patients, aged 18-40 yr old, received either sevoflurane by mask to a predetermined end-tidal concentration (%ETsevo) or propofol by target-controlled infusion (effect site) while breathing spontaneously. After sufficient time for equilibration, LOC was assessed by lack of response to mild prodding. The up-down method of Dixon was used to determine the hypnotic target concentration at 50% response (LOC50). No statistically significant difference in LOC50 was noted between men and women for sevoflurane (0.83% +/- 0.1% and 0.92% +/- 0.09% ET, respectively). Men required significantly more propofol than women (2.9 +/- 0.2 versus 2.7 +/- 0.1 mu g/mL, respectively). However, there was no difference in the bispectral index (BIS) at LOC for men or women with either hypnotic anesthetic. This investigation identified a small, statistically significant difference in hypnotic requirement at LOC50 between men and women with propofol but not with sevoflurane. As defined by BIS, men and women had equivalent hypnotic states at LOC50, indicating that gender had no clinically significant effect on hypnotic requirements. However, BIS at a defined clinical end-point (LOC50) was significantly different between the sevoflurane and propofol groups, suggesting that neurophysiological effects of these anesthetics may be different.

Download full-text

Full-text

Available from: Jay W. Johansen, Jun 24, 2015
0 Followers
 · 
90 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To determine propofol concentration in the cerebral spinal fluid (CSF) of neurosurgical patients and carry out a preliminary population pharmacodynamic study. Twenty-seven elective neurosurgical patients (12 men and 15 women) aged 17-74 years received propofol in a bolus dose of 2 mg/kg for 5 min and an infusion of 10 mg/kg per h for 5 min. Frequent CSF samples were drawn and assayed for propofol concentration. The bispectral index (BIS) was used to measure the drug effect. All data were analyzed first with the Excel software package, then pharmacodynamics modeling was performed using the NONMEM software package. The CSF concentration was related to the drug effect with linear and sigmoid Emax models. The parameters for the linear addictive model were a=1.11 and b=95.4. The parameters for the linear exponential model were a=1.05 and b=92.7. The parameters for the sigmoid E(max) model were E(max)=119, EC(50)=53.6 ng/mL, and N=1.51. When the covariates of age, weight and sex were considered, the parameters of models, objective function, the standard error of the mean and the prediction error were not optimized. Linear additive, linear exponential and sigmoid E(max) models can be used to describe the pharmacodynamics of propofol with respect to the concentration in CSF. In this small population, age (17-74 years), weight (47-98 kg) and sex did not influence any of the pharmacodynamic parameters of propofol. To verify these preliminary results, a larger study population is required.
    Acta Pharmacologica Sinica 06/2006; 27(5):629-34. DOI:10.1111/j.1745-7254.2006.00309.x · 2.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Loss of consciousness (LOC) and immobility to surgical incision seem to be mediated at different levels of the central nervous system. Pharmacologic studies of hypnotic agents have previously focused on combinations of either volatile or intravenous anesthetics. This study examined the combination of inhaled sevoflurane and intravenous propofol at these two clinically relevant anesthetic end points. Thirty-six elective surgical patients were initially enrolled. Conditions approximating steady state were obtained for sevoflurane and target-controlled propofol infusions. Patients were sequentially evaluated for LOC (loud voice plus mild prodding) and immobility to surgical incision. The study was designed using the Dixon up-down method. The observed propofol effect target with 50% response plus sevoflurane (0.46% end-tidal concentration) was 1.2 microg/ml (95% confidence interval, 1.1-1.3 microg/ml). It was not significantly different from that predicted (1.5 microg/ml; 95% confidence interval, 1.2-1.7 microg/ml) by simple additivity. The effective plasma concentration of propofol that suppressed movement to skin incision in 50% of patients was 5.4 microg/ml (95% confidence interval, 4.8-6.0 microg/ml) plus sevoflurane (0.86%) and was not significantly different from that predicted by additivity (5.4 microg/ml; 95% confidence interval, 4.8-5.9 microg/ml). Both analyses had adequate power (90%) to detect a significant change (+/-19 to 25%) from predicted value. Repeated-measures analysis of variance identified a Bispectral Index value of 70 as the break point between those who responded at LOC or did not. Propofol and sevoflurane interact in a simple additive manner to produce LOC and immobility to surgical incision, suggesting a common mechanism or a single site of action. These clinical observations are consistent with a single site of interaction at the gamma-aminobutyric acid type A receptor.
    Anesthesiology 07/2006; 104(6):1170-5. DOI:10.1097/00000542-200606000-00011 · 6.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Neocortical dynamics and signals reflect spatiotemporal cortical synchronization as well as functional condition and modulation by subcortical projecting structures that determine the brain state. However, neurotransmitters interact and neuronal function and signals also reflect non-neuronal factors that should (but not necessarily are, or can) be taken into proper consideration in neuroscience. Examples in this regard are the CNS modulation by spontaneous or induced changes in metabolism (e.g. glucose, ammonia), blood flow, pO(2), pCO(2), hormones (thyroxine; sexual hormones, ATCH) and neurohormonal interaction, maturation, aging, temperature, light-dark regulation of serotonine, histamine and dopamine/melatonin/vitamin B12 secretion and interaction, etc. Hormones also regulate the (functional) maturation and differentiation between sexes both during development and in adult life. These factors interact with each other and individually or collectively can account for unexplained or underestimated individual variability; on occasions, may become critical variables in animal or human research. In specific instances, variability is the information of interest. However, physiological variability due to neuronal or non-neuronal factors can interact with the experimental setups or affect electrophysiological signals to extents that can result in biased findings in otherwise controlled studies. An "inverse problem" difficult to approach may ensue in both animal and human research; in several instances, the specificity of brain signals for the investigated function may require experimental validation.
    Clinical Neurophysiology 01/2007; 117(12):2569-83. DOI:10.1016/j.clinph.2006.04.026 · 2.98 Impact Factor